Mitochondrial transcription factor B2 (TFB2M), responsible for the mitochondrial DNA (mtDNA) transcription and compacting, is expressed in ovarian cancer patients, and is associated with poor prognosis, immunosuppressive TME and macrophage polarization. The gene discussed is TFB2M; the disease is ovarian cancer.